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INTRODUCTION
Of all forms of tuberculosis, tuberculous
meningitis (TBM) still carries a high mortality and
morbidity. Infections of the central nervous system,
unlike other infections cause irreparable damage
unless diagnosed early and promptly treated. The
resulting neurological sequelae can manifest either
during treatment or subsequently. Long term follow
up of treated TBM patients is therefore essential to
find out the course of the residual lesions and also
the relapse rates. This report gives the 5 year follow
up status of 128 survivors out of 185 patients
treated for TBM with short course chemotherapy.
The study was undertaken by the Tuberculosis
Research Centre in collaboration with the Institute
of Child Health and Hospital for Children, Chennai
from where the patients were drawn.
MATERIAL AND METHODS
A total of 215 patients aged between 1 and 12
years, who had not received more than 2 weeks of
previous anti-tuberculosis chemotherapy and had
no evidence of renal or hepatic disease and no optic
atrophy were admitted to the study. They were
treated for 9 months with one of the following
regimens.
Regimen-I : 2 SHER3Z3/7R2H2 : Patients received
streptomycin, isoniazid and ethambutol daily
supplemented with rifampicin and pyrarinamide
thrice a week for the first 2 months followed by
rifampicin and isoniazid twice a week for the next 7
months.
Regimen-II: 2SHER2Z2/7R2H2: Patients were
treated with streptomycin, isoniazid and ethambutol
daily supplemented with rifampicin and
pyrazinamide twice a week for the first 2 months
followed by rifampicin and isoniazid twice a week
for the next 7 months.
In addition to anti-tuberculosis drugs. non-
specific therapy was also given in the form of
intravenous fluids, anti-oedema measures, anti-
convulsants and vitamins.  Steroids were
administered to all the patients for a period of 6 to
12 weeks.
The results (awaiting publication in The Indian
Journal of Tuberculosis) were similar in both the
regimens with a mortality rate of 31%. There was a
clear association between the stage on admission
and the mortality rate, the latter being highest in
stage III patients and lowest in stage I. At the end of
treatment, there were 128 survivors. 66 (36%) with
neurological sequelae and 62 (34%) with complete
recovery.
Neurological sequelae were classified as follows
Patients classified as with severe residual damage
either remained unconscious or even if they had
regained consciousness, were incapable of
independent existence. Moderate residual damage
included defects like involuntary movements.
hemiparesis and substantial mental impairment.
Mild sequelae included hyperactivity, irritability,
mild perceptual defects and limited motor
impairment like facial weakness or monoparesis.
All the patients who completed 9 months of
* Paper presented at the 51st National Conference on Tuberculosis and Chest Diseases held at Bangalore, 3-6 Novem-
ber, 1996; ** Tuberculosis Research Centre, Chennai 600 031
Correspondence :  Dr. Padma Ramachandran, Deputy Director, Tuberculosis Research Centre, Mayor V. R.
Ramanathan Road, Chetput, Chennai 600 031
126 PADMA RAMCHANDRAN ET AL.
treatment were seen once a month till 24 months,
once in 3 months till 36 months and thereafter once
in 6 months till 60 months. The period of follow up
was 51 months after completion of therapy. At all
these visits, a complete neurological examination
was done on all the patients. Lumbar puncture and
CSF examination for cell count biochemical and
bacteriological examination was repeatedly
undertaken for those who had abnormal CSF
findings at the end of treatment, till the results
became normal.
RESULTS
Table 1 shows the status at the end of 5 years for
the 128 patients who completed the treatment.
Eleven patients died during the follow up period - 7
due to TBM sequelae and 4 due to non tuberculous
causes. The remaining 117 patients were seen upto
60th month from the start of treatment.
Of the 5 patients with severe sequelae at the end
of treatment, 4 patients died-all due to sequelae, in
the 14th,  15th,  19th and the 44th months
respectively, while the fifth patient showed
improvement.
Of the 43 patients with moderate sequelae, 2
patients died of TBM sequelae in the 11 th and 30th
months while 2 others died of non-tuberculous
causes. In 36 patients the status remained the same
while 2 patients improved to mild sequelae and one
had complete recovery.
Of the 18 patients with mild sequelae, 2 patients
died, the first patient due to non-tuberculous cause
while, the second relapsed at the 12th month and
died in the 31 st month despite intensive therapy for
9 months. Ten patients maintained their status while
3 other developed moderate sequelae, namely,
secondary epilepsy. Three had a complete recovery.
Of the 62 patients who had complete recovery
status quo was maintained in 54 patients, while 7
developed sequale-1 patient developed diabetes
insipidus, 3 had secondary epilepsy. while the
remaining 3 had behaviour problems. One patient
died of a non-tuberculous cause.
Seven patients had CSF abnormality (increased
protein level) at the end of treatment. All the 7 had
hydrocephalus and 6 of them underwent ventriculo-
peritoneal shunt surgery. In the surgery group, the
CSF protein level became normal in all the patients.
In the 7th patient whose parents refused surgery. the
last CSF examination at the 47th month was still
abnormal. Repeat lumbar puncture was no
possible because of non-cooperation. The patient
was alive at 60th month with moderate sequelae.
Relapses during follow-up
In all, 3 patients relapsed, 1 in regimen I and 2 in
regimen II. All of them had clinical signs and
symptoms of meningitis with abnormal CSF
biochemical findings and bacteriological positivity.
In the first patient who had mild sequelae at the end
of treatment and relapsed in the 12th month, the
CSF cultures (both initial and at the time of relapse)
were sensitive to all the drugs. Despite retreatment
with intensive therapy for 9 months, the patient died
in the 31st month. The last CSF was normal
biochemically and bacteriologically. The remaining
2 patients (1 with mild sequelae and the other with
moderate) relapsed in the 11 th and 22nd month of
follow-up (from the commencement of treatment)
respectively. The first patient relapsed with
organisms sensitive to all the drugs while the 2nd
relapsed with organisms resistant to streptomycin
and isoniazid (both initially and at the time of
relapse). Both the patients were treated with
Table I. Status at 5 years in relation to status at the end of 9 months
Status at No. of
9 months pts.
Deaths after 9 months
TBM seq. Non. TB Sev.
Seq.
Status at the end of 5 years
Mod. Mild Comp.
Seq. Seq. Rec.
Severe Seq. 5 4 0 0 1 0 0
Moderate Seq. 43 2 2 0 36 2 I
Mild Seq. 18 1 1 0 3 10 3
Comp. recovery 62 0 1 0 4 3 54
All 128 7 4 0 44 15 58
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intensive chemotherapy and both recovered with
moderate sequelae.  The CSF at  the end of
retreatment was normal biochemically and
bacteriologically.
DISCUSSION
There are very few reports available on long
term follow-up of patients treated for tuberculous
meningitis. In our earlier report on long term status
(4½ - 8 years) of 119 survivors treated for TBM2
the salient features were : out of 10 deaths due to
TBM sequelae, 9 occurred in those who had severe
sequelae at the end of treatment and of the 52
patients who were classified as fully recovered, 10
developed mild to moderate sequelae during
follow-up period. Fitzsimons3 treated 289 patients
between the years 1946 and 1959. There were 198
survivors who were followed for a period of 2 to 15
years after discharge and the results showed that
122 patients (62%) had a complete recovery, 42
(21%) had minimal restriction, 19 (10%) had
moderate disability and 15 (8%) severe disability. A
follow up study on 100 survivors out of a total of
170 children treated for TBM between 1947 and
1955 is reported by Lorber4. He followed them for a
period of 5 to 13 years and found neurological
sequelae in 23 patients. In another study by Miller
et aI5 116 patients were treated between 1947 and
1957 and the results showed that 36 (31%) patients
died and 80 (69%) survived. The survivors were
followed for a period of at least 2 years and residual
neurological sequelae were found in 38 (48%)
patients.
The salient feature of the present study is that the
coverage was 100% despite 50% of the patients
hailing from semi-urban and rural areas. This was
possible because of initial and periodic subsequent
motivation. The relapse rate was low and 10
patients (in the complete recovery and mild
sequelae group) developed late sequelae during the
follow up period stressing the necessity for long
term follow up of treated TBM patients.
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